Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Current Assets (2021 - 2025)

Prime Medicine filings provide 5 years of Current Assets readings, the most recent being $181.3 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 14.44% to $181.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $181.3 million, a 14.44% decrease, with the full-year FY2025 number at $181.3 million, down 14.44% from a year prior.
  • Current Assets hit $181.3 million in Q4 2025 for Prime Medicine, down from $231.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $296.6 million in Q4 2022 to a low of $121.3 million in Q2 2025.
  • Median Current Assets over the past 5 years was $211.9 million (2024), compared with a mean of $204.0 million.
  • Biggest five-year swings in Current Assets: crashed 51.8% in 2023 and later surged 48.2% in 2024.
  • Prime Medicine's Current Assets stood at $270.6 million in 2021, then rose by 9.62% to $296.6 million in 2022, then crashed by 51.8% to $143.0 million in 2023, then surged by 48.2% to $211.9 million in 2024, then fell by 14.44% to $181.3 million in 2025.
  • The last three reported values for Current Assets were $181.3 million (Q4 2025), $231.4 million (Q3 2025), and $121.3 million (Q2 2025) per Business Quant data.